Author Archives: Harvard Law School Forum on Corporate Governance and Financial Regulation

Second Circuit on Scope of Whistleblower Protection

On November 10, 2015, the employer in a high-profile whistleblower-retaliation case [1] advised the United States Court of Appeals for the Second Circuit that it “will not be pursuing a petition for writ of certiorari with the Supreme Court of the United States” with respect to the appellate court’s recent pro-whistleblower decision concerning the scope of […]

Click here to read the complete post
Posted in Accounting & Disclosure, Court Cases, Legislative & Regulatory Developments, Practitioner Publications, Securities Litigation & Enforcement | Tagged , , , , , , , , | Comments Off on Second Circuit on Scope of Whistleblower Protection

Legislation to Facilitate Capital Formation

[December 1, 2015], conference committee members for the House and Senate agreed on a five-year transportation bill. While this type of legislation is rarely of interest to participants in the capital markets, the bill includes several provisions that will improve upon the JOBS Act and facilitate capital formation transactions. The legislation is expected to be […]

Click here to read the complete post
Posted in Accounting & Disclosure, Legislative & Regulatory Developments, Practitioner Publications, Securities Regulation | Tagged , , , , , , , , , , , , | Comments Off on Legislation to Facilitate Capital Formation

Reply

In a December 10, 2015 post to the Harvard Corporate Governance Blog, Professors Lucian Bebchuk, Alon Brav, Wei Jiang, and Thomas Keusch (“BBJK”) suggest that a study the four of us have recently coauthored, Hedge Fund Activism and Long-Term Firm Value (the “CGSW study”), “overlooks prior opposing evidence on the subject, offers a flawed empirical […]

Click here to read the complete post
Posted in Academic Research, Accounting & Disclosure, Empirical Research | Tagged , , , , , , , , , | Comments Off on Reply

The Long-Term Value of the Poison Pill

Nearly six years ago, Air Products made an unsolicited all-cash bid to acquire Airgas for $60 per share (later increased to $70), to which the board of directors of Airgas said “no.” Based on the Airgas directors’ unanimous judgment—informed by months of thoughtful review and analysis—that Airgas was worth more than Air Products was offering, whether […]

Click here to read the complete post
Posted in Boards of Directors, Corporate Elections & Voting, Mergers & Acquisitions, Practitioner Publications | Tagged , , , , , , , , , , , , , , | Comments Off on The Long-Term Value of the Poison Pill

Lessons Learned from a Highly Successful Proxy Contest Defense

Recently, our client, a NYSE-listed publicly traded firm, successfully defended against a proxy contest brought by an activist fund that in the first part of this year acquired 5.5% stake in the company. Following on earlier indications that it would do so, the fund notified the company in September that it intended to nominate six […]

Click here to read the complete post
Posted in Boards of Directors, Corporate Elections & Voting, Institutional Investors, Practitioner Publications | Tagged , , , , , , , , , , , | Comments Off on Lessons Learned from a Highly Successful Proxy Contest Defense

Oversight of the Financial Stability Oversight Council

Thank you for inviting me to testify regarding the Financial Stability Oversight Council (Council). Below I highlight my perspective on the Council and my role on it. The Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act) established the Council to provide comprehensive monitoring of the stability of our nation’s financial system. Specifically, the Council […]

Click here to read the complete post
Posted in Banking & Financial Institutions, Financial Crisis, Financial Regulation, Practitioner Publications, Regulators Materials, Securities Regulation, Speeches & Testimony | Tagged , , , , , , , , , , , , , , , | Comments Off on Oversight of the Financial Stability Oversight Council

U.S. Antitrust Agencies and Challenges to Mergers

Yesterday [December 7, 2015] was a busy day for antitrust enforcement, as the United States Federal Trade Commission sued to block the proposed merger of Staples, Inc. with Office Depot, Inc., and the Department of Justice announced that AB Electrolux and General Electric Company have abandoned their proposed transaction after five months of litigation with […]

Click here to read the complete post
Posted in Legislative & Regulatory Developments, Mergers & Acquisitions, Practitioner Publications, Securities Litigation & Enforcement, Securities Regulation, Speeches & Testimony | Tagged , , , , , , , , | Comments Off on U.S. Antitrust Agencies and Challenges to Mergers

Chair White Statement on Use of Derivatives

The Commission will consider two separate recommendations from the staff today [December 11, 2015]. First, we will consider and vote on a recommendation from the staff of the Division of Investment Management to propose an updated and more comprehensive approach to the use of derivatives by mutual funds and exchange-traded funds, closed-end funds, and business […]

Click here to read the complete post
Posted in Accounting & Disclosure, Derivatives, Financial Regulation, International Corporate Governance & Regulation, Practitioner Publications, Regulators Materials, Securities Regulation, Speeches & Testimony | Tagged , , , , , , , , , , , , , , , | Comments Off on Chair White Statement on Use of Derivatives

Protecting Investors through Proactive Regulation of Derivatives

Today [December 11, 2015], the Commission considers new rules that are designed to protect investors by addressing the use of derivatives by registered investment companies. As demonstrated by the 2008 financial crisis, and the economic turmoil that followed, years of regulatory complacency and deregulation enabled an unregulated derivatives marketplace to cause significant losses to investors. […]

Click here to read the complete post
Posted in Boards of Directors, Derivatives, Financial Regulation, Practitioner Publications, Regulators Materials, Securities Litigation & Enforcement, Securities Regulation, Speeches & Testimony | Tagged , , , , , , , , , , , , , | Comments Off on Protecting Investors through Proactive Regulation of Derivatives

Dissenting Statement on Use of Derivatives

Today [December 11, 2015], we are considering a proposed new exemptive rule that addresses the use of derivatives and financial commitment transactions by registered investment companies and business development companies (collectively, “funds”). This proposal is the third in a series of initiatives aimed at ensuring that the Commission’s regulatory program fully addresses the increasingly complex […]

Click here to read the complete post
Posted in Accounting & Disclosure, Derivatives, Financial Regulation, Practitioner Publications, Regulators Materials, Securities Regulation, Speeches & Testimony | Tagged , , , , , , , , , , , , , , | Comments Off on Dissenting Statement on Use of Derivatives